Alembic Ltd.
Snapshot View

View in App

Prices View details >>

68.50 -1.00 ▼-1.4%

27 January 2023, 04:01:00 PM
Volume: 11,527

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.alembiclimited.com
Market Cap 1,765.38 Cr.
Enterprise Value(EV) 1,756.72 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 5.83 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 11.76 Trailing Twelve Months Ending 2022-09
Industry PE 32.90 Trailing Twelve Months Ending 2022-09
Book Value / Share 94.10 Trailing Twelve Months Ending 2022-09
Price to Book Value 0.73 Calculated using Price: 68.50
Dividend Yield 2.62 Period Ending 2022-03
No. of Shares Subscribed 25.68 Cr. 256,781,828 Shares
FaceValue 2
Company Profile
Alembic was incorporated in 1907 as Alembic Chemical Works Company, primarily engaged in production of tinctures and alcohol at Baroda. Later the company set up distillery plant for pharmaceutical purposes at Baroda. It started manufacturing of cough syrup, vitamins, tonics and sulphur drugs.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-1.44%
1 Week
-3.72%
1 Month
-3.52%
3 Month
-2.70%
6 Month
-2.42%
1 Year
-31.43%
2 Year
-27.13%
5 Year
+1.78%
10 Year
+735.37%

Ratios View Details >>

9 years 2010-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 11.83 5.58 3.71 3.21 4.18 3.58 7.08 0.75 3.60
Return on Capital Employed (%) 10.54 3.82 3.82 3.12 4.44 3.91 7.12 0.94 4.10
Return on Assets (%) 3.82 2.88 3.25 2.94 3.88 3.39 6.80 0.71 3.42

Balance Sheet View Details >>

Particulars 9 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 528 803 911 1,086 1,209 1,418 2,297 2,497 2,416
Non Curr. Liab. 38 15 13 14 9 7 53 68 61
Curr. Liab. 82 58 68 59 49 46 59 68 82
Minority Int.
Equity & Liab. 648 876 992 1,159 1,266 1,471 2,409 2,632 2,559
Non Curr. Assets 458 706 801 972 1,167 1,308 2,307 2,489 2,396
Curr. Assets 189 169 191 187 99 163 102 143 163
Misc. Exp. not W/O
Total Assets 648 876 992 1,159 1,266 1,471 2,409 2,632 2,559

Profit Loss View Details >>

Particulars 9 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 144 128 147 125 124 74 74 78 97
Other Income 22 29 31 37 29 94 11 89 66
Total Income 166 156 178 162 153 167 84 167 163
Total Expenditure -135 -122 -140 -114 -106 -71 -63 -64 -74
PBIDT 30 35 38 48 48 97 21 103 89
Interest -1 0 0 0 0 0 0 0 0
Depreciation -6 -6 -5 -4 -3 -3 -4 -5 -6
Taxation 1 -1 1 -2 -4 0 -3 -12 -9
Exceptional Items -3 -6
PAT 24 25 27 42 41 93 14 86 74
Minority Interest
Share Associate 82 210 118 121 172 236 329 136 76
Other Related Items
Consolidated Net Profit 107 235 145 163 213 329 343 222 150
Adjusted EPS 4 9 5 6 8 13 13 9 6

Cash Flow View Details >>

Particulars 8 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 22 10 52 24 22 7 -2 -18
Cash Fr. Inv. 5 -5 -47 -22 72 57 -35 19
Cash Fr. Finan. -25 -5 -5 -3 -92 -6 -15 -6
Net Change 2 0 0 -1 1 57 -52 -5
Cash & Cash Eqvt 3 2 2 1 2 59 6 1

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 70.41 70.88 70.88 70.88 70.88 70.88 70.88 70.88 70.88
Public 29.59 29.12 29.12 29.12 29.12 29.12 29.12 29.12 29.12
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Tue, 24 Jan 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we enclose herewith a copy of advertisement related to notice of loss of share certificates published by the Company on behalf of the registered shareholder(s) and their legal heir(s) in Business Standard (English Edition) on 24th January 2023.
Mon, 23 Jan 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
With reference to the captioned subject please find enclosed herewith the intimation dated 23rd January 2023 received from Link lntime India Private Limited Registrar and Share Transfer Agent regarding lost/misplaced share certificate(s) of the Company for which the shareholder has requested duplicate share certificate(s).
Tue, 10 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
With reference to the captioned matter please find enclosed herewith a Certificate under Regulation 74(5) of SEBI Depositories and Participants) Regulations 2018 for the quarter ended 31st December 2022 received from M/s. Link Intime IndiaPrivate Limited Registrar and Share Transfer Agent of our Company.

Technical Scans View Details >>

Fri, 27 Jan 2023
High Delivery Percentage High Delivery Percentage
Higher Delivery Quantity Higher Delivery Quantity
Higher Delivery Quantity and Percentage Higher Delivery Quantity and Percentage
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 249,710.79 1,040.75 +0.1%
Divi's Laboratories Ltd. 89,875.72 3,385.55 +1.5%
Cipla Ltd. 84,895.40 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. 71,960.69 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. 61,265.20 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. 52,047.83 1,537.85 -1.3%
Abbott India Ltd. 45,216.39 21,279.00 0.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.84 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 30.03 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-12 32.18 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.75 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.97 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.63 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-09 51.28 21,279.00 0.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.70 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 7.41 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-12 3.74 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.27 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.24 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.17 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-09 16.66 21,279.00 0.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 0.04 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 0.00 21,279.00 0.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 29.95 21,279.00 0.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 29.95 21,279.00 0.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 4,919.27 21,279.00 0.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 798.70 21,279.00 0.0%

FAQ's On Alembic Ltd.

What is Alembic share price?
Can I buy Alembic shares now?
What is the Dividend Yield of Alembic?
What is the Market Cap of Alembic?
What are the key metrics to analyse Alembic?
What is the 52 Week High and Low of Alembic?
What is the trend of Alembic share price?